featured
Durability of Intravitreal Anti-VEGF Agents and Evolution of Retreatment Criteria for Diabetic Macular Edema
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Current Opinion in Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Enhanced durability and evolution of retreatment criteria of intravitreal antivascular endothelial growth factor agents for diabetic macular edema
Curr Opin Ophthalmol 2024 May 01;35(3)197-204, NK Mandava, AE Kuriyan, AC Ho, J Hsu, CD Regillo, MA KlufasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.